Ultimately, the integration of fundamental science, technological innovation, and clinical collaboration will establish ferroptosis as a cornerstone of personalized kidney disease management
10.1016/j.envint.2012.12.003 Environ Int
The nitrocellulose membranes were immunoblotted with primary antibodies against acyl-CoA synthetase long-chain family member 4 (ACSL4) (1:1000, Santa cruz), Bax (1:1000, Cell signaling), Bcl-2 (1:1000, Cell signaling), DRP1 (1:1000, Cell signaling), GAPDH (1:5000 Abcam), GPX4 (1:1000, Abcam), MLKL (1:1000, Invitrogen), OPA1 (1:1000, Cell signaling), pDRP1 (Ser616) (1:1000, Cell signaling), pRIPK3 (Ser232) (1:1000, Cell signaling), and RIPK3 (1:1000, Cell signaling) overnight at 4 C, and then incubated with the appropriate secondary antibody (1:1000, Santa cruz)
Bingham, N.S